BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Frequently asked questions
What sector does BillionToOne, Inc. Class A Common Stock (BLLN) operate in?
BillionToOne, Inc. Class A Common Stock belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is BillionToOne, Inc. Class A Common Stock (BLLN) current stock price?
As of the latest data, BillionToOne, Inc. Class A Common Stock stock price is $93.39, with a previous close of $91.65. BillionToOne, Inc. Class A Common Stock gained $1.74 in the last trading session, representing a 1.9% increase.
What is BillionToOne, Inc. Class A Common Stock (BLLN) current market capitalization?
BillionToOne, Inc. Class A Common Stock market cap is approximately 3.98 billion.
What is BillionToOne, Inc. Class A Common Stock (BLLN) Earnings Per Share (EPS)?
The trailing EPS is $0.33, and the forward EPS is $0.70.
What is BillionToOne, Inc. Class A Common Stock (BLLN) Price-to-Earnings (P/E) ratio?
BillionToOne, Inc. Class A Common Stock current P/E ratio is 283, with a forward P/E of 133.41.
What is BillionToOne, Inc. Class A Common Stock (BLLN) EBITDA?
BillionToOne, Inc. Class A Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 21.51 million.
Does BillionToOne, Inc. Class A Common Stock (BLLN) pay dividends?
No. BillionToOne, Inc. Class A Common Stock does not pay a dividend.
How did BillionToOne, Inc. Class A Common Stock (BLLN) perform in its most recent earnings report?
In the last report (June 30, 2026), BillionToOne, Inc. Class A Common Stock posted an EPS surprise of 3,489% and a revenue surprise of 7.79%.
What is BillionToOne, Inc. Class A Common Stock (BLLN) beta (volatility) score?
BillionToOne, Inc. Class A Common Stock has a beta of -0.120, indicating lower volatility than the overall market.
